Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy.
Journal article
Guldvik IJ. et al, (2024), World J Urol, 42
Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features.
Journal article
Rao S. et al, (2024), Genome Med, 16
Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer.
Journal article
Mah CY. et al, (2024), Br J Cancer
Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence.
Journal article
Sushentsev N. et al, (2023), Proc Natl Acad Sci U S A, 120
Molecular Anatomy of Prostate Cancer and Its Implications in Active Surveillance and Early Intervention Strategies
Journal article
Figiel S. et al, (2023), Anatomia, 2, 300 - 319
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.
Journal article
Figiel S. et al, (2023), Mol Cancer, 22
Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis.
Journal article
Lehto T-PK. et al, (2023), Int J Cancer
Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics.
Journal article
Desai TA. et al, (2023), medRxiv
Untangling heterogeneity: From complexity to prediction.
Journal article
Mills IG., (2023), Int J Cancer
Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.
Journal article
Rao SR. et al, (2023), Int J Mol Sci, 24
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?
Journal article
Cussenot O. et al, (2023), BJU Int
Autocrine activation of MAPK signaling mediates intrinsic tolerance to androgen deprivation in LY6D prostate cancer cells.
Journal article
Steiner I. et al, (2023), Cell Rep, 42
Data from Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist–Treated Prostate Cancers
Other
Maxwell PJ. et al, (2023)
Data from Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist–Treated Prostate Cancers
Other
Maxwell PJ. et al, (2023)
Data from O-GlcNAc Transferase – An Auxiliary Factor or a Full-blown Oncogene?
Other
Itkonen HM. et al, (2023)
Data from O-GlcNAc Transferase – An Auxiliary Factor or a Full-blown Oncogene?
Other
Itkonen HM. et al, (2023)
Data from VPRBP Functions Downstream of the Androgen Receptor and OGT to Restrict p53 Activation in Prostate Cancer
Other
Poulose N. et al, (2023)
Data from VPRBP Functions Downstream of the Androgen Receptor and OGT to Restrict p53 Activation in Prostate Cancer
Other
Poulose N. et al, (2023)